- Eroxon® is Haleon's first offering
in the sexual health space
- Clinical studies show Eroxon® is safe
and effective in men with ED
- Eroxon® is available now for Amazon
pre-order; available on shelves and online at most major retailers
in October 2024
WARREN,
N.J., Sept. 3, 2024 /PRNewswire/ --
Eroxon®, the first-and-only FDA cleared gel available
without a prescription for the treatment of erectile dysfunction
(ED), is now available for pre-order in the United States through Amazon and will
be available at most major retailers in October 2024.
Eroxon® is clinically proven to help men get an
erection within 10 minutes to foster physical intimacy (individual
results may vary). The treatment stimulates nerve endings in the
penis to help men with ED get and maintain an erection during
sex. Given existing prescription solutions may take up to an
hour to work (based on labels), Eroxon® addresses a
significant unmet need for men experiencing ED.
Clinical study results show that Eroxon® is safe and
effective in men with ED. While ED can be caused by underlying
physical conditions, psychological challenges such as stress,
anxiety, depression, and other mental health issues may also
contribute to ED, especially in younger men. Eroxon®
aims to help men with ED enhance intimacy and connection in their
relationships, fostering closer and more fulfilling
partnerships.
Lisa Paley, President,
North America at Haleon,
said: "At Haleon, we have a clear purpose to deliver better
everyday health with humanity. Introducing Eroxon to U.S. consumers
reflects our belief that sexual health is a critical part of
wellness. We understand how important making meaningful and
intimate connections are to one's wellbeing, and Eroxon helps
achieve just that. We are proud to take this bold step to make this
first-of-its-kind over-the-counter (OTC) gel treatment accessible
to the millions of men in the U.S. who are affected by
ED."
Gerald Brock, MD, FRCSC,
Haleon Partner, said: "The body of scientific evidence for
Eroxon supports it as an effective, fast-acting, and accessible OTC
ED treatment with an excellent safety profile."
How to use Eroxon®:
- Unscrew cap. Pierce the tube seal with top of cap.
- Squeeze tube firmly to empty all the contents onto finger(s),
which will provide the correct dose.
- Massage the gel onto the head of your penis for about 15
seconds. If you are uncircumcised, gently pull your foreskin back
as far as comfortable before applying the gel. It may take a few
attempts to achieve the desired effect.
- You can apply the gel, or your partner can apply the gel
to your penis as part of foreplay. In a clinical study, partners
applied the product for the male as part of foreplay, which
resulted in better outcomes.
For more information on Eroxon® and ED, visit
eroxon.us, and to preorder visit Amazon.
About Erectile Dysfunction
ED is a common condition,
impacting 1 in 4 men over the age of 221 – that's 30
million men.2 Men with ED may have trouble getting or
maintaining an erection firm enough for sexual activity. Some men
have trouble on occasion, while others may not be able to get an
erection at all. ED typically becomes more prevalent as you age,
impacting half of men over the age of 40.3 However,
mild-to-moderate symptoms often go undetected and untreated,
especially in younger men. For more information about erectile
dysfunction (ED), please visit our website eroxon.us.
About Eroxon®
Eroxon®, launched
by Haleon in the United States, is
the first-and-only FDA cleared gel available without a prescription
for the treatment of erectile dysfunction (ED). The treatment works
directly on the penis to stimulate nerve endings leading to
increased blood flow to help men get and keep an erection for
sex/intimacy. Eroxon® is a convenient
and accessible ED treatment for millions of men. For more
information, please visit our website eroxon.us.
About Haleon U.S.
Haleon (NYSE: HLN) is a leading
global consumer health company with a purpose to deliver better
everyday health with humanity. Haleon's product portfolio
spans five major categories: Oral Health, Pain Relief, Respiratory
Health, Digestive Health, and Wellness. Built on trusted science,
innovation, and deep human understanding, Haleon's U.S. brands
include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin,
Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident,
Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS,
Voltaren, and more. For more information on Haleon and its brands,
please visit www.haleon.com or contact
USMediaRelations@haleon.com.
- Selvin E, Burnett A, Platz E Prevalence and risk factors for
erectile dysfunction in the U S Am Jour of Med 2007 (120)
151-157
- National Institutes of Health (NIH) website http://kidney niddk
nih gov/kudiseases/pubs/ED/index aspx Downloaded 5/14/12
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay
JB. Impotence and its medical and psychosocial correlates: results
of the Massachusetts Male Aging Study. J Urol. 1994
Jan;151(1):54-61. doi: 10.1016/s0022-5347(17)34871-1. PMID:
8254833.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haleon-announces-the-launch-of-eroxon-the-first-and-only-fda-cleared-otc-gel-for-erectile-dysfunction-available-for-us-preorder-without-a-prescription-302235236.html
SOURCE Haleon